桂枝加术附汤治疗退行性膝骨关节炎疼痛的疗效与安全性:随机安慰剂对照盲法试验
本研究为随机、安慰剂对照、患者与评估者盲法的优效性临床试验,计划纳入80例膝骨关节炎患者,按1:1随机分配至桂枝加术附汤或安慰剂组,每日3次每次2.5g,治疗4周,随访4周。主要结局为第4周膝痛视觉模拟量表评分较基线的变化,次要结局包括临床相关性、最小临床重要差异、功能障碍、生活质量及安全性。
要点
- 桂枝加术附汤是东亚常用治疗膝骨关节炎的汉方药,本研究旨在评估其疗效与安全性。
- 试验采用随机、安慰剂对照、患者与评估者双盲设计,以膝痛VAS变化为主要结局。
- 除对乙酰氨基酚作为救援药物外,不允许合并使用其他缓解膝痛的干预措施。
核心结论
- 该方案旨在评估桂枝加术附汤治疗退行性膝骨关节炎的疗效与安全性,为草药治疗膝骨关节炎提供基础证据。
研究设计与样本
- 随机、安慰剂对照、患者与评估者盲法、优效性临床试验,计划纳入80例膝骨关节炎患者,在两家韩国韩医院按1:1随机分配。
关键数值与推荐
- 桂枝加术附汤或安慰剂剂量为2.5g,每日三次,治疗4周,治疗结束后追加4周随访。
- 主要结局为第4周膝痛视觉模拟量表评分较基线的变化。
- 次要结局包括临床相关性、最小临床重要差异、功能障碍、生活质量及安全性。
- 允许对乙酰氨基酚作为救援药物,禁止其他缓解膝痛的合并治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Degenerative knee osteoarthritis is a leading cause of disability in the elderly. If patients do not respond to pharmacological or nonpharmacological intervention, total knee replacement surgery is recommended. However, owing to the contraindications and adverse effects of surgery, the need for a new treatment strategy is emerging. Traditional herbal medicine is a widely used intervention in east Asia to treat knee osteoarthritis. Gyejigachulbutang is one of the frequently prescribed herbal formulae. The aim of our study is to evaluate the efficacy and safety of gyejigachulbutang for knee osteoarthritis. METHODS: This study is a randomized, placebo-controlled, patient and assessor blinded, superiority clinical trial. A total of 80 patients with knee osteoarthritis will be enrolled. The participants will be randomly assigned to the gyejigachulbutang or placebo group in a 1:1 ratio in two Korean medical hospitals. Every participant will take gyejigachulbutang or placebo at a dose of 2.5 g three times a day for 4 weeks. Additional follow-up will be conducted 4 weeks after treatment completion. Any concomitant treatment to relive knee pain will not be allowed except for rescue medicine (acetaminophen). The primary outcome will be a comparison of the change in the visual analogue scale score for knee pain from baseline to visit 3 (week 4) for both the treatment and placebo groups. Secondary outcomes include clinical relevance, minimal clinically important difference, disability, quality of life, and safety. DISCUSSION: This protocol presents a research methodology for clinical trials of gyejigachulbutang for knee osteoarthritis. Various secondary outcomes make this trial more informative. Our trial will provide fundamental evidence for knee osteoarthritis management via herbal medicine treatment. TRIAL REGISTRATION: Clinical Research Information Service (CRIS), KCT0003024 . Registered on 25 July 2018.
引用
- Sul JU, Kim MK, Leem J, et al. Efficacy and safety of gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-Tang, Keishikajutsubuto, TJ-18) for knee pain in patients with degenerative knee osteoarthritis: a randomized, placebo-controlled, patient and assessor blinded clinical trial. Trials. 2019. PMID: 30782208. doi:10.1186/s13063-019-3234-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。